Skip to Main Content

Author Details

Lorenzo Beretta
Scleroderma Clinic, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
2001
151
35
PMIDPaper TitleJournal TitlePublished Year
32859611Systemic lupus erythematosus and COVID-19: what we know so far.Ann Rheum Dis2023
37744053Systemic sclerosis and primary biliary cholangitis: Longitudinal data to determine the outcomes.J Scleroderma Relat Disord2023
37536947Transcutaneous auricular branch vagal nerve stimulation as a non-invasive add-on therapeutic approach for pain in systemic sclerosis.RMD Open2023
37046475Anti-U11/U12 Antibodies as a Rare but Important Biomarker in Patients with Systemic Sclerosis: A Narrative Review.Diagnostics (Basel)2023
37142531Corrigendum to 'Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus' [J. Autoimmun. 136 (April 2023) 103025].J Autoimmun2023
36996699Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus.J Autoimmun2023
36813476Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study.RMD Open2023
36868782Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology.RMD Open2023
36707842Proteomic aptamer analysis reveals serum markers that characterize preclinical systemic sclerosis (SSc) patients at risk for progression toward definite SSc.Arthritis Res Ther2023
36865099Patients with fibrosis from non-alcoholic steatohepatitis have heterogeneous intrahepatic macrophages and therapeutic targets.medRxiv2023
36482877Nuclear Receptor Subfamily 4A Signaling as a Key Disease Pathway of CD1c+â¿¿Dendritic Cell Dysregulation in Systemic Sclerosis.Arthritis Rheumatol2023
36040182Longitudinal global transcriptomic profiling of preclinical systemic sclerosis reveals molecular changes associated with disease progression.Rheumatology (Oxford)2023
34559222Hypoxia and TLR9 activation drive CXCL4 production in systemic sclerosis plasmacytoid dendritic cells via mtROS and HIF-2α.Rheumatology (Oxford)2022
35845065The Systolic Pulmonary Arterial Pressure Liaises Impaired Cardiac Autonomic Control to Pro-inflammatory Status in Systemic Sclerosis Patients.Front Cardiovasc Med2022
35349420Sjögren's syndrome and other rare and complex connective tissue diseases: an intriguing liaison.Clin Exp Rheumatol2022
35349419The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET.Clin Exp Rheumatol2022
35349418Off-label use of mycophenolate mofetil in the treatment of rare and complex rheumatic connective tissue diseases.Clin Exp Rheumatol2022
35632419The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study.Vaccines (Basel)2022
35587927The added value of right ventricular function normalized for afterload to improve risk stratification of patients with pulmonary arterial hypertension.PLoS One2022
36675983Sympatho-Vagal Dysfunction in Systemic Sclerosis: A Follow-Up Study.Life (Basel)2022
35970982Comparison between the first and second COVID-19 waves in Internal Medicine wards in Milan, Italy: a retrospective observational study.Intern Emerg Med2022
35908642Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature.Autoimmun Rev2022
36361554Defining the Role of Monocytes in Sjögren's Syndrome.Int J Mol Sci2022
36203063Publisher Correction: The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET.Nat Rev Rheumatol2022
36294335The Effect of Body Fat Distribution on Systemic Sclerosis.J Clin Med2022
35922121Chronic glucocorticoid maintenance treatment is associated with the risk of SARS-CoV-2 infection in patients with systemic lupus erythematosus who received vaccination.Ann Rheum Dis2022
33004331Genomic Risk Score impact on susceptibility to systemic sclerosis.Ann Rheum Dis2021
33742673Anti-RNPC-3 antibody predicts poor prognosis in patients with interstitial lung disease associated to systemic sclerosis.Rheumatology (Oxford)2021
33573268Implication of miR-126 and miR-139-5p in Plasmacytoid Dendritic Cell Dysregulation in Systemic Sclerosis.J Clin Med2021
33668942Cardiovascular Autonomic Control, Sleep and Health Related Quality of Life in Systemic Sclerosis.Int J Environ Res Public Health2021
34722574Interstitial Lung Disease Associated With Autoimmune Rheumatic Diseases: Checklists for Clinical Practice.Front Med (Lausanne)2021
34478882Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year.Clin Immunol2021
34834498Xeroderma Pigmentosum: General Aspects and Management.J Pers Med2021
34096881Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes.Ann Rheum Dis2021
33408338The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET.Nat Rev Rheumatol2021
31424086Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and Sjögrens syndrome.Eur J Immunol2020
31780281Discovering new metabolite alterations in primary sjögren's syndrome in urinary and plasma samples using an HPLC-ESI-QTOF-MS methodology.J Pharm Biomed Anal2020
31637433Cardiopulmonary exercise testing in a combined screening approach to individuate pulmonary arterial hypertension in systemic sclerosis.Rheumatology (Oxford)2020
32002799Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient).J Nephrol2020
33333969Angiopoietin-2 Promotes Inflammatory Activation in Monocytes of Systemic Sclerosis Patients.Int J Mol Sci2020
32574572Letter to the editor: Immunomodulation by phosphodiesterase-4 inhibitor in COVID-19 patients.Metabolism2020
32927376COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patients.Semin Arthritis Rheum2020
32284212CXCL4 triggers monocytes and macrophages to produce PDGF-BB, culminating in fibroblast activation: Implications for systemic sclerosis.J Autoimmun2020
32528464Fatty Acid and Carnitine Metabolism Are Dysregulated in Systemic Sclerosis Patients.Front Immunol2020
32553611Autoantibodies to stratify systemic sclerosis patients into clinically actionable subsets.Autoimmun Rev2020
32301427Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of the scleroderma spectrum.Clin Exp Rheumatol2020
32561607Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patients.Ann Rheum Dis2020
32165035Safety and effectiveness of abatacept in systemic sclerosis: The EUSTAR experience.Semin Arthritis Rheum2020
30793699Histone modifications underlie monocyte dysregulation in patients with systemic sclerosis, underlining the treatment potential of epigenetic targeting.Ann Rheum Dis2019
35382143Abatacept to treat chronic intestinal pseudo-obstruction in five systemic sclerosis patients with a description of the index case.J Scleroderma Relat Disord2019
  • 1 - 50 of 151

Recommended Authors

Mount Sinai Hospital.
Career Start Year 2011
Number of shared co-authors 0
Yale University School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Geisel School of Medicine at Dartmouth
Career Start Year 2010
Number of shared co-authors 4
Schroeder Arthritis Institute, Krembil Research Institute, University Health Network
Career Start Year 2009
Number of shared co-authors 0
The University of Queensland
Career Start Year 2008
Number of shared co-authors 1
Medical Subspecialities Institute, Cleveland Clinic
Career Start Year 2008
Number of shared co-authors 0
Geisel School of Medicine at Dartmouth
Career Start Year 2008
Number of shared co-authors 4
Vanderbilt University Medical Center
Career Start Year 2005
Number of shared co-authors 0
Schroeder Arthritis Institute, Krembil Research Institute, University Health Network
Career Start Year 2005
Number of shared co-authors 0
Institute of Rheumatology, Charles University
Career Start Year 2003
Number of shared co-authors 0
Toronto Western Hospital, University of Toronto
Career Start Year 2003
Number of shared co-authors 3
University of Pittsburgh
Career Start Year 2003
Number of shared co-authors 0
Betsi Cadwaladr University Health Board
Career Start Year 2001
Number of shared co-authors 0
Peking Union Medical College Hospital (PUMCH)
Career Start Year 1998
Number of shared co-authors 2
Tokyo Medical and Dental University
Career Start Year 1998
Number of shared co-authors 0
Novartis Pharma AG
Career Start Year 1995
Number of shared co-authors 0
Geisel School of Medicine at Dartmouth
Career Start Year 1995
Number of shared co-authors 7
Corbus Pharmaceuticals Holdings
Career Start Year 1994
Number of shared co-authors 2
Krembil Research Institute, University Health Network
Career Start Year 1993
Number of shared co-authors 0
Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation
Career Start Year 1993
Number of shared co-authors 7
Kaohsiung Veterans General Hospital
Career Start Year 1992
Number of shared co-authors 0
Centre de recherche du Centre hospitalier universitaire de Quebec-Universite Laval
Career Start Year 1991
Number of shared co-authors 5
Hospital for Special Surgery and Weill Cornell Medical College
Career Start Year 1989
Number of shared co-authors 3
Centre Hospitalo-Universitaire de Rouen
Career Start Year 1988
Number of shared co-authors 0
Albert Einstein College of Medicine
Career Start Year 1986
Number of shared co-authors 1
University of Occupational and Environmental Health
Career Start Year 1986
Number of shared co-authors 2
University of Toronto
Career Start Year 1976
Number of shared co-authors 0
Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital
Career Start Year 1975
Number of shared co-authors 5
Schroeder Arthritis Institute, Krembil Research Institute, University Health Network
Career Start Year 1966
Number of shared co-authors 0
US Department of Veterans Affairs Medical Center
Career Start Year 1956
Number of shared co-authors 7

Collaborators

Co-authored papers 52
U.O. Immunologia Clinica-Centro di Riferimento per le Malattie Autoimmuni Sistemiche
Co-authored papers 48
Co-authored papers 42
Co-authored papers 24
University of Texas McGovern Medical School
Co-authored papers 21
Departamento de Genetica e Instituto de Biotecnologia, Universidad de Granada
Co-authored papers 19
Co-authored papers 12
University of Texas McGovern Medical School
Co-authored papers 10
Co-authored papers 9
Co-authored papers 8
Co-authored papers 6
University of Texas
Co-authored papers 5
Co-authored papers 5
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
National Center for Rare Diseases, Istituto Superiore di Sanita
Co-authored papers 3
Co-authored papers 3
Yale School of Medicine
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Institute of Clinical Molecular Biology, Kiel University
Co-authored papers 2
Cedars-Sinai Medical Center
Co-authored papers 2
Southend Hospital NHS Trust
Co-authored papers 2
University of Pennsylvania Perelman School of Medicine
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Baylor College of Medicine
Co-authored papers 2
Co-authored papers 1